Health

Markets

Moderna CEO: COVID-19 vaccine surplus possible in 2022

Moderna Inc. CEO Stephane Bancel said Friday that the company is on track to produce 1 billion doses of its COVID-19 vaccine this year, but warned that with manufacturers producing large quantities, there could be an oversupply in 2022.